Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3917-3933
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3917
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3917
Feature | Fraction selected in cross-validation |
All HCC vs CLD | |
PIVKA-II | 1.00 |
hsa-miR-21-5p | 0.86 |
hsa-miR-320d | 0.10 |
hsa-miR-339-3p | 0.02 |
hsa-miR-320a | 0.01 |
hsa-miR-423-5p | 0.00 |
Early HCC vs CLD | |
PIVKA-II | 1.00 |
hsa-miR-21-5p | 0.60 |
hsa-miR-320d | 0.18 |
hsa-miR-652-3p | 0.16 |
hsa-miR-339-3p | 0.02 |
hsa-miR-221-3p | 0.01 |
hsa-miR-30b-5p | 0.01 |
hsa-miR-10b-5p | 0.00 |
hsa-miR-15b-5p | 0.00 |
Early HCC vs cirrhosis | |
PIVKA-II | 1.00 |
hsa-miR-652-3p | 0.64 |
hsa-miR-221-3p | 0.26 |
hsa-miR-21-5p | 0.05 |
hsa-miR-423-5p | 0.04 |
hsa-miR-320a | 0.01 |
hsa-miR-339-3p | 0.01 |
hsa-miR-320d | 0.00 |
- Citation: Malik J, Klammer M, Rolny V, Chan HLY, Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, Köhler B, Swiatek-de Lange M. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2022; 28(29): 3917-3933
- URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3917.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3917